Chemistry:SB-399885

From HandWiki
Short description: Chemical compound
SB-399885
SB-399885.svg
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
ChEMBL
Chemical and physical data
FormulaC18H21Cl2N3O4S
Molar mass446.34 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

SB-399885 is a drug which is used in scientific research. It acts as a potent, selective and orally active 5-HT6 receptor antagonist, with a Ki of 9.0nM. SB-399885 and other 5-HT6 antagonists show nootropic effects in animal studies,[1][2] as well as antidepressant and anxiolytic effects which are comparable to and synergistic with drugs such as imipramine and diazepam,[3][4][5] and have been proposed as potential novel treatments for cognitive disorders such as schizophrenia[6] and Alzheimer's disease.

References

  1. "Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task". Pharmacology, Biochemistry, and Behavior 81 (3): 673–82. July 2005. doi:10.1016/j.pbb.2005.05.005. PMID 15964617. 
  2. "SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models". European Journal of Pharmacology 553 (1–3): 109–19. December 2006. doi:10.1016/j.ejphar.2006.09.049. PMID 17069795. 
  3. "Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression". Neuropharmacology 52 (5): 1274–83. April 2007. doi:10.1016/j.neuropharm.2007.01.007. PMID 17320917. 
  4. "The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors". European Journal of Pharmacology 580 (3): 355–60. February 2008. doi:10.1016/j.ejphar.2007.11.022. PMID 18096153. 
  5. "The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats". European Journal of Pharmacology 582 (1–3): 88–93. March 2008. doi:10.1016/j.ejphar.2007.12.013. PMID 18234190. 
  6. "5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus". Brain Research 1134 (1): 70–8. February 2007. doi:10.1016/j.brainres.2006.11.060. PMID 17207474.